Quick Order Cart

Cat. No. ARG27567

HOMER1 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The HOMER1 Knockout HAP1 Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal HAP1 population with disrupted HOMER1, a scaffold protein that links group I mGluRs to Shank, ITPR, and TRPC channel complexes, thereby regulating calcium signaling and synaptic plasticity. This haploid human model enables loss-of-function dissection of HOMER1-dependent pathways in calcium dynamics and actin reorganization. Applications include mechanistic studies of mGluR signaling, calcium imaging, co-immunoprecipitation, and drug screening for neuropsychiatric disorders such as schizophrenia, autism spectrum disorder, and major depressive disorder. Users can monitor pathway perturbations via Western blot, RT-qPCR, and immunofluorescence.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    HOMER1

    Gene Identifier

    NCBI Gene ID 9456

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The HOMER1 Knockout HAP1 Polyclonal Cells comprise a polyclonal population of HAP1 cells engineered with CRISPR/Cas9-mediated disruption of the HOMER1 gene, generating a loss-of-function model for studying HOMER1-dependent signaling. This human knockout cellular model offers a renewable and genetically defined resource for investigating the scaffolding functions of HOMER1 in signal transduction pathways.

The host HAP1 cell line is a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia line. Its haploid karyotype simplifies genetic manipulation and facilitates recessive phenotype screening, making it a well-established platform for forward and reverse genetic studies. HAP1 cells retain expression of many signaling components, allowing the assessment of HOMER1??s molecular functions in a mammalian cellular context.

HOMER1 encodes a postsynaptic density scaffold protein that constitutively binds group I metabotropic glutamate receptors (mGluR1/5) and couples them to downstream effectors. Through its EVH1 domain, HOMER1 interacts with Shank family scaffold proteins, inositol 1,4,5-trisphosphate receptors (ITPR1/2/3), transient receptor potential canonical channels (TRPC1/4/5), PIKE, and dynamin-3 (DNM3), organizing a signaling complex that regulates intracellular calcium dynamics and actin cytoskeleton reorganization. HOMER1 expression is regulated by neuronal activity, CREB, BDNF, and calcium influx, and it mediates mGluR1/5 signaling to IP3R-mediated calcium release and TRPC-mediated calcium influx, as well as ERK1/2 activation. These interactions are critical for synaptic plasticity, dendritic spine morphology, and glutamatergic transmission.

Although HAP1 is not of neural origin, HOMER1 is expressed in this cell line and its disruption allows the dissection of conserved scaffold-mediated signaling mechanisms involved in calcium handling and actin remodeling. This knockout model provides a simplified cellular environment to study how loss of HOMER1 affects the coupling of mGluRs to intracellular pathways without the complexity of neuronal networks. It is particularly useful for analyzing core HOMER1 interactions with its partners and for screening potential modulators of these pathways in a high-throughput-compatible format.

Researchers can employ these polyclonal knockout cells for a range of functional studies, including calcium imaging to monitor mGluR-evoked calcium transients, co-immunoprecipitation to map altered protein?Cprotein interactions, and subcellular fractionation to assess changes in scaffolding complex assembly. The model is suitable for neuropsychiatric disease research, enabling drug screening for schizophrenia, autism spectrum disorder, and major depressive disorder, as well as for investigating synaptic plasticity mechanisms at the molecular level. Standard assays such as Western blotting, RT-qPCR, immunofluorescence, and reporter assays can be used to validate pathway perturbations. For inquiries regarding lot-specific performance or customization, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)